Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results

Kedhi, E., Windecker, S., Latib, A., Kirtane, A. J., Kandzari, D., Mehran, R., Price, M. J., Abizaid, A., Simon, D. I., Zaman, A., Fabbiocchini, F., Tie, C., van ‘t Hof, A., de la Torre Hernandez, J. M., Hammett, C. J., McLaurin, B., Potluri, S., Smith, T., Waksman, R., … Stone, G. W. (2022). Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results. Journal of the Society for Cardiovascular Angiography & Interventions, 1(5), 100441. https://doi.org/10.1016/j.jscai.2022.100441
Authors:
Elvin Kedhi
Stephan Windecker
Azeem Latib
Ajay J Kirtane
David Kandzari
Roxana Mehran
Matthew J Price
Alexandre Abizaid
Daniel I Simon
Azfar Zaman
Franco Fabbiocchini
Charlies Tie
Arnoud van 't Hof
Jose M de la Torre Hernandez
Christopher J Hammett
Brent McLaurin
Srinivasa Potluri
Timothy Smith
Ron Waksman
Michael Ragosta
Maria Parke
Te-Hsin Lung
Gregg W Stone
Affiliated Authors:
Ajay J Kirtane
Author Keywords:
diabetes mellitus
high bleeding risk
percutaneous coronary intervention
zotarolimus-eluting stent
Publication Type:
Article
Unique ID:
10.1016/j.jscai.2022.100441
PMID:
Publication Date:
Data Source:
PubMed

Record Created: